See more : Alpha Group Inc. (3322.T) Income Statement Analysis – Financial Results
Complete financial analysis of Arix Bioscience plc (ARIX.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Arix Bioscience plc, a leading company in the Biotechnology industry within the Healthcare sector.
- Cornerstone OnDemand, Inc. (CSOD) Income Statement Analysis – Financial Results
- First Milling Co. (2283.SR) Income Statement Analysis – Financial Results
- BOC Hong Kong (Holdings) Limited (BHKLY) Income Statement Analysis – Financial Results
- Natura &Co Holding S.A. (NTCO) Income Statement Analysis – Financial Results
- Zhejiang Leapmotor Technology Co., Ltd. (9863.HK) Income Statement Analysis – Financial Results
Arix Bioscience plc (ARIX.L)
About Arix Bioscience plc
Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, novel therapeutics, innovative technologies, medical innovation comprising healthcare and life sciences. It seeks to invest globally. The firm employs an evergreen approach to funding. It primarily makes investments from its own balance sheet. The firm prefers to take board seat. The firm exit when the optimum value has been reached. Arix Bioscience plc is formerly known as Perceptive Bioscience Investments Limited. Arix Bioscience plc was founded in 2015 and is based in London, United Kingdom.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|
| Revenue | 112.00K | 340.00K | 477.00K | 506.00K | 1.33M | 1.86M | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 112.00K | 340.00K | 477.00K | 506.00K | 1.33M | 1.86M | 0.00 |
| Gross Profit Ratio | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 208.00K | 0.00 |
| General & Administrative | 2.81M | 1.83M | 2.65M | 3.93M | 4.60M | 4.59M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.81M | 1.83M | 2.65M | 3.93M | 4.60M | 4.59M | 0.00 |
| Other Expenses | 2.60M | 2.97M | 5.14M | 8.57M | 10.43M | 9.84M | 0.00 |
| Operating Expenses | 5.41M | 4.80M | 7.79M | 12.50M | 15.03M | 14.64M | 0.00 |
| Cost & Expenses | 5.41M | 4.80M | 7.79M | 12.50M | 15.03M | 14.64M | 0.00 |
| Interest Income | 1.58M | 156.00K | 101.00K | 769.00K | 720.00K | 1.00K | 0.00 |
| Interest Expense | 53.05M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 229.00K | 209.00K | 335.00K | 446.00K | 503.00K | 506.00K | 22.82K |
| EBITDA | 25.70M | 51.15M | -142.11M | 47.10M | -64.37M | -17.83M | 0.00 |
| EBITDA Ratio | 22,950.00% | 15,045.29% | -29,791.61% | 9,307.31% | -4,847.36% | -959.88% | 0.00% |
| Operating Income | 25.48M | 50.95M | -142.44M | 46.65M | 40.80M | -3.59M | 0.00 |
| Operating Income Ratio | 22,745.54% | 14,983.82% | -29,861.84% | 9,219.17% | 3,072.52% | -193.27% | 0.00% |
| Total Other Income/Expenses | 8.48M | -2.70M | -1.69M | -1.14M | 5.29M | -447.00K | 0.00 |
| Income Before Tax | -27.58M | -61.08M | 126.30M | -75.57M | 42.76M | -7.69M | 0.00 |
| Income Before Tax Ratio | -24,624.11% | -17,965.88% | 26,478.20% | -14,934.39% | 3,219.95% | -414.11% | 0.00% |
| Income Tax Expense | -4.00K | 112.03M | -268.74M | -5.88M | 5.88M | -221.00K | 0.00 |
| Net Income | -27.58M | -173.11M | 395.04M | -69.69M | 36.88M | -7.47M | 0.00 |
| Net Income Ratio | -24,620.54% | -50,915.59% | 82,818.24% | -13,771.74% | 2,776.96% | -402.21% | 0.00% |
| EPS | -0.21 | -1.27 | 2.78 | -0.54 | 0.29 | -0.09 | 0.00 |
| EPS Diluted | -0.21 | -1.27 | 2.78 | -0.54 | 0.29 | -0.09 | 0.00 |
| Weighted Avg Shares Out | 132.36M | 136.43M | 142.34M | 129.95M | 128.52M | 78.73M | 90.12M |
| Weighted Avg Shares Out (Dil) | 132.36M | 136.43M | 142.34M | 129.95M | 128.52M | 78.73M | 90.12M |
Source: https://incomestatements.info
Category: Stock Reports